Cargando…
CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19
BACKGROUND: Lower muscle mass is a known predictor of unfavorable outcome, but its prognostic impact on COVID-19 patients is unknown. PURPOSE: To investigate the contribution of CT-derived muscle status in predicting clinical outcomes in COVID-19 patients. MATERIALS AND METHODS: Clinical/laboratory...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radiological Society of North America
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971428/ https://www.ncbi.nlm.nih.gov/pubmed/33724065 http://dx.doi.org/10.1148/radiol.2021204141 |
_version_ | 1783666610667520000 |
---|---|
author | Schiaffino, Simone Albano, Domenico Cozzi, Andrea Messina, Carmelo Arioli, Roberto Bnà, Claudio Bruno, Antonio Carbonaro, Luca A. Carriero, Alessandro Carriero, Serena Danna, Pietro S. C. D’Ascoli, Elisa De Berardinis, Claudia Della Pepa, Gianmarco Falaschi, Zeno Gitto, Salvatore Malavazos, Alexis E. Mauri, Giovanni Monfardini, Lorenzo Paschè, Alessio Rizzati, Roberto Secchi, Francesco Vanzulli, Angelo Tombini, Valeria Vicentin, Ilaria Zagaria, Domenico Sardanelli, Francesco Sconfienza, Luca M. |
author_facet | Schiaffino, Simone Albano, Domenico Cozzi, Andrea Messina, Carmelo Arioli, Roberto Bnà, Claudio Bruno, Antonio Carbonaro, Luca A. Carriero, Alessandro Carriero, Serena Danna, Pietro S. C. D’Ascoli, Elisa De Berardinis, Claudia Della Pepa, Gianmarco Falaschi, Zeno Gitto, Salvatore Malavazos, Alexis E. Mauri, Giovanni Monfardini, Lorenzo Paschè, Alessio Rizzati, Roberto Secchi, Francesco Vanzulli, Angelo Tombini, Valeria Vicentin, Ilaria Zagaria, Domenico Sardanelli, Francesco Sconfienza, Luca M. |
author_sort | Schiaffino, Simone |
collection | PubMed |
description | BACKGROUND: Lower muscle mass is a known predictor of unfavorable outcome, but its prognostic impact on COVID-19 patients is unknown. PURPOSE: To investigate the contribution of CT-derived muscle status in predicting clinical outcomes in COVID-19 patients. MATERIALS AND METHODS: Clinical/laboratory data and outcomes (intensive care unit [ICU] admission and death) were retrospectively retrieved for patients with reverse transcriptase polymerase chain reaction-confirmed COVID-19, who underwent chest CT on admission in four hospitals in Northern Italy from February 21 to April 30, 2020. Extent and type of pulmonary involvement, mediastinal lymphadenopathy, and pleural effusion were assessed. Cross-sectional areas and attenuation of paravertebral muscles were measured on axial CT images at T5 and T12 vertebral level. Multivariable linear and binary logistic regression, including calculation odds ratios (OR) with 95% confidence intervals (CIs), were used to build four models to predict ICU admission and death, tested and compared using receiver operating characteristic curve (ROC) analysis. RESULTS: A total 552 patients (364 men; median age 65 years, interquartile range 54–75) were included. In a CT-based model, lower-than-median T5 paravertebral muscle area showed the highest ORs for ICU admission (OR 4.8, 95% CI 2.7–8.5; P<.001) and death (OR 2.3, 95% CI 1.0–2.9; P=.027). When clinical variables were included in the model, lower-than-median T5 paravertebral muscle area still showed the highest ORs both for ICU admission (OR 4.3; 95% CI 2.5–7.7; P<.001) and death (OR 2.3, 95% CI 1.3–3.7; P=.001). At ROC analysis, the CT-based model and the model including clinical variables showed the same area under the curve (AUC) for ICU admission prediction (AUC 0.83, P=.380) and were not different in predicting death (AUC 0.86 versus AUC 0.87, respectively, P=.282). CONCLUSION: In hospitalized patients with COVID-19, lower muscle mass on CT was independently associated with ICU admission and hospital mortality. |
format | Online Article Text |
id | pubmed-7971428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Radiological Society of North America |
record_format | MEDLINE/PubMed |
spelling | pubmed-79714282021-03-18 CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19 Schiaffino, Simone Albano, Domenico Cozzi, Andrea Messina, Carmelo Arioli, Roberto Bnà, Claudio Bruno, Antonio Carbonaro, Luca A. Carriero, Alessandro Carriero, Serena Danna, Pietro S. C. D’Ascoli, Elisa De Berardinis, Claudia Della Pepa, Gianmarco Falaschi, Zeno Gitto, Salvatore Malavazos, Alexis E. Mauri, Giovanni Monfardini, Lorenzo Paschè, Alessio Rizzati, Roberto Secchi, Francesco Vanzulli, Angelo Tombini, Valeria Vicentin, Ilaria Zagaria, Domenico Sardanelli, Francesco Sconfienza, Luca M. Radiology Original Research BACKGROUND: Lower muscle mass is a known predictor of unfavorable outcome, but its prognostic impact on COVID-19 patients is unknown. PURPOSE: To investigate the contribution of CT-derived muscle status in predicting clinical outcomes in COVID-19 patients. MATERIALS AND METHODS: Clinical/laboratory data and outcomes (intensive care unit [ICU] admission and death) were retrospectively retrieved for patients with reverse transcriptase polymerase chain reaction-confirmed COVID-19, who underwent chest CT on admission in four hospitals in Northern Italy from February 21 to April 30, 2020. Extent and type of pulmonary involvement, mediastinal lymphadenopathy, and pleural effusion were assessed. Cross-sectional areas and attenuation of paravertebral muscles were measured on axial CT images at T5 and T12 vertebral level. Multivariable linear and binary logistic regression, including calculation odds ratios (OR) with 95% confidence intervals (CIs), were used to build four models to predict ICU admission and death, tested and compared using receiver operating characteristic curve (ROC) analysis. RESULTS: A total 552 patients (364 men; median age 65 years, interquartile range 54–75) were included. In a CT-based model, lower-than-median T5 paravertebral muscle area showed the highest ORs for ICU admission (OR 4.8, 95% CI 2.7–8.5; P<.001) and death (OR 2.3, 95% CI 1.0–2.9; P=.027). When clinical variables were included in the model, lower-than-median T5 paravertebral muscle area still showed the highest ORs both for ICU admission (OR 4.3; 95% CI 2.5–7.7; P<.001) and death (OR 2.3, 95% CI 1.3–3.7; P=.001). At ROC analysis, the CT-based model and the model including clinical variables showed the same area under the curve (AUC) for ICU admission prediction (AUC 0.83, P=.380) and were not different in predicting death (AUC 0.86 versus AUC 0.87, respectively, P=.282). CONCLUSION: In hospitalized patients with COVID-19, lower muscle mass on CT was independently associated with ICU admission and hospital mortality. Radiological Society of North America 2021-03-16 /pmc/articles/PMC7971428/ /pubmed/33724065 http://dx.doi.org/10.1148/radiol.2021204141 Text en 2021 by the Radiological Society of North America, Inc. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Original Research Schiaffino, Simone Albano, Domenico Cozzi, Andrea Messina, Carmelo Arioli, Roberto Bnà, Claudio Bruno, Antonio Carbonaro, Luca A. Carriero, Alessandro Carriero, Serena Danna, Pietro S. C. D’Ascoli, Elisa De Berardinis, Claudia Della Pepa, Gianmarco Falaschi, Zeno Gitto, Salvatore Malavazos, Alexis E. Mauri, Giovanni Monfardini, Lorenzo Paschè, Alessio Rizzati, Roberto Secchi, Francesco Vanzulli, Angelo Tombini, Valeria Vicentin, Ilaria Zagaria, Domenico Sardanelli, Francesco Sconfienza, Luca M. CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19 |
title | CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19 |
title_full | CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19 |
title_fullStr | CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19 |
title_full_unstemmed | CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19 |
title_short | CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19 |
title_sort | ct-derived chest muscle metrics for outcome prediction in patients with covid-19 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971428/ https://www.ncbi.nlm.nih.gov/pubmed/33724065 http://dx.doi.org/10.1148/radiol.2021204141 |
work_keys_str_mv | AT schiaffinosimone ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT albanodomenico ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT cozziandrea ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT messinacarmelo ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT arioliroberto ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT bnaclaudio ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT brunoantonio ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT carbonarolucaa ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT carrieroalessandro ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT carrieroserena ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT dannapietrosc ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT dascolielisa ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT deberardinisclaudia ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT dellapepagianmarco ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT falaschizeno ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT gittosalvatore ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT malavazosalexise ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT maurigiovanni ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT monfardinilorenzo ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT paschealessio ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT rizzatiroberto ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT secchifrancesco ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT vanzulliangelo ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT tombinivaleria ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT vicentinilaria ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT zagariadomenico ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT sardanellifrancesco ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 AT sconfienzalucam ctderivedchestmusclemetricsforoutcomepredictioninpatientswithcovid19 |